Measurement of Spinal Kinematics During Various Movements

September 25, 2025 updated by: Haute Ecole de Santé Vaud

Differences in Spinal Kinematics During Various Activities Between Asymptomatic Subjects and Patients With Chronic Low Back Pain

Participants will perform movements while receiving different visual cues. Spinal kinematics will be measured during these movements and compared between asymptomatic and CLBP participants. Participants will come for a unique session.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

CLBP patients will be recruited through a multimodal rehabilitation program at Lausanne University Hospital, medical doctors or physiotherapists' consultations.

Healthy controls will be a convenience sample recruited using flyers and emails, notably posted at the Lausanne University Hospital, the University of Health Professions in Lausanne (HESAV) and at the University of Lausanne.

Description

Inclusion Criteria:

- sufficient French level to understand the instructions for the tests, the information sheet, the consent form.

For CLBP patients:

- diagnosis of non-specific low back pain (pain from lower ribs to gluteal folds) for more than 3 months.

For asymptomatic participants:

  • no history of LBP requiring medical attention during the last two years
  • no other concomitant pain or condition that could compromise the evaluation of lumbar kinematics.

Exclusion Criteria:

  • pregnancy
  • skin allergy to tape
  • body mass index (BMI) above 32

For patients with CLBP only:

  • specific low back pain (such as the presence of infection, rheumatological or neurological diseases, spinal fractures, tumours)
  • any known important spinal deformities
  • previous back surgery that limits spinal mobility
  • high level of pain at the time of experiment that prevents repeated movements (severity and irritability)
  • other concomitant pain or condition that could compromise the evaluation of spinal kinematics.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chronic low back pain (CLBP)
All CLBP patients should present with non-specific low back pain (pain from lower ribs to gluteal folds) for more than 3 months.
Other: Visual cues
Participants will be asked to move following cues displayed on a screen in front of them.
Asymptomatic controls
Asymptomatic participants should have had no history of LBP requiring medical attention during the last two years and no other concomitant pain or condition that could compromise the evaluation of lumbar kinematics.
Other: Visual cues
Participants will be asked to move following cues displayed on a screen in front of them.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spinal kinematics
Time Frame: Day 1
Spinal kinematics will be measured at the lumbar and thoracic spine in degrees
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Haute Ecole de Santé Vaud

Collaborators

University of Lausanne Hospitals
Clinique Romande de Readaptation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2025

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

April 2, 2020

First Submitted That Met QC Criteria

April 2, 2020

First Posted (Actual)

April 6, 2020

Study Record Updates

Last Update Posted (Estimated)

September 30, 2025

Last Update Submitted That Met QC Criteria

September 25, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LBP2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe